Autologous Stem Cell Transplantation in Chronic Myeloid Leukemia

Seminars in Hematology

Volumn 44, Issue 4, 2007, Pages 252-258

  Olavarria, Eduardo ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; IDARUBICIN; IMATINIB; INTERFERON; MELPHALAN; PROTEIN TYROSINE KINASE INHIBITOR; ROQUINIMEX;

APHERESIS; ARTICLE; AUTOGRAFT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG MEGADOSE; ERADICATION THERAPY; GRAFT FAILURE; HEALTH SURVEY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; MINIMAL RESIDUAL DISEASE; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; RADIATION DOSE; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; DRUG RESISTANCE, NEOPLASM; EVIDENCE-BASED MEDICINE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKAPHERESIS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MIDDLE AGED; NEOPLASM, RESIDUAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROTEIN KINASE INHIBITORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 35348942833     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2007.08.003     Document Type: Article

References (53)

1. Buckner C.D., Stewart P., Clift R.A., et al. Treatment of blastic transformation of chronic granulocytic leukaemia by chemotherapy, total body irradiation and infusion of cryopreserved autologous marrow. Exp Hematol 6 (1978) 96-109
2. Goldman J.M., Th'ng K.H., Park D.S., et al. Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukemia in blast-cell transformation. Br J Haematol 40 (1978) 185-195
3. Goldman J.M., Catovsky D., Hows J., Spiers A.S.D., and Galton D.A.G. Cryopreserved peripheral blood cells functioning as autografts in patients with chronic granulocytic leukaemia in transformation. Br Med J 1 (1979) 1310-1313
4. Haines M.E., Goldman J.M., and Worsley. Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: Probable prolongation of survival in some patients. Br J Haematol 58 (1984) 711-721
5. Butturini A., Keating A., Goldman J., and Gale R.P. Autotransplants in chronic myelogenous leukaemia: strategies and results. Lancet 335 (1990) 1255-1258
6. Reiffers J., Trouette R., Marit G., et al. Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: A report of 47 cases. Br J Haematol 77 (1991) 339-345
7. Reiffers J., Mahon F.X., Boiron J.M., et al. Autografting in chronic myeloid leukaemia: an overview. Leukemia 10 (1996) 385-388
8. Pigneux A., Faberes C., Boiron J.M., et al. Autologous stem cell transplantation in chronic myeloid leukemia: A single center experience. Bone Marrow Transplant 24 (1999) 265-270
9. Hehlmann R., Hochhaus A., Berger U., and Reiter A. Current trends in the management of chronic myelogenous leukemia. Ann Hematol 79 (2000) 345-354
10. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83 (1994) 3068-3076
11. Daley G.Q. Rationalizing autotransplant strategies for chronic myeloid leukemia. Leuk Lymphoma 21 (1996) 353-358
12. Bhatia R., and Forman S.J. Autologous transplantation for the treatment of chronic myelogenous leukemia. Hematol Oncol Clin North Am 12 (1998) 151-172
13. Miller J.S. Innovative therapy for chronic myelogenous leukemia. Hematol Oncol Clin North Am 12 (1998) 173-206
14. Carella A.M., and Frassoni F. ICE, mini-ICE or high-dose hydroxyurea to mobilize Philadelphia [Ph]-negative PBPC in chronic myelogenous leukaemia. Br J Haematol 95 (1996) 213-214
15. Carella A.M., Lerma E., Corsetti M.T., et al. Autografting with Philadelphia chromosome negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. Blood 83 (1999) 1534-1539
16. Bouzgarrou R, Reiffers J: Cellules souches circulantes et LMC: Mmodalités de prélèvement, congélation, décongélation, reconstitution hématologique après greffe. Presented at the Réunion du groupe Hémobiologie du FAG, Paris, France, October 22, 1991
17. Reiffers J. Autologous transplantation in chronic myelogenous leukemia. Blood Transfusion Immunohematol 28 (1985) 509-520
18. Coulombel L., Kalousek D.K., Eaves C.J., Gupta C.M., and Eaves A.C. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome positive chronic myelogenous leukemia. N Engl J Med 308 (1983) 1493-1498
19. + cell population from peripheral blood of chronic myelogenous leukemia patients contains BCR-ABL negative progenitor cells. Exp Hematol 23 (1995) 1509-1514
20. lo population in chronic myeloid leukemia: An analysis using interphase fluorescence in situ hybridization. Blood 86 (1995) 737-743
21. Petzer A.L., Eaves C.J., Lansdorp P.M., et al. Characterization of primitive subpopulation of normal and leukemic cells in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 88 (1996) 2162-2171
22. Brito-Babapulle F., Bowcock S.J., Marcus R.E., et al. Autografting for patients with chronic myeloid leukaemia in chronic phase: Peripheral blood stem cells may have a finite capacity for maintaining haematopoiesis. Br J Haematol 73 (1989) 76-81
23. Reiffers J., Goldman J.M., Meloni G., Cahn J.Y., and Apperley J. Autologous stem cell transplantation (Auto-SCT) for chronic myeloid leukemia (CML) in chronic phase: A report of the European Blood and Marrow Transplant (EBMT) Group. 22nd Annual Meeting of the EBMT, Vienna (Austria) Bone Marrow Transplant 17 (1996) S3 (suppl 1, abstr 56)
24. Reiffers J., Taylor K., Gluckman E., et al. Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferon. Br J Haematol 102 (1998) 639-646
25. Archimbaud E., Michallet M., Philip I., et al. Granulocyte colony-stimulating factor given in addition to interferon-alpha to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia. Br J Haematol 99 (1997) 678-684
26. Olavarria E., Parker S., Craddock C., et al. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: Effect of granulocyte-colony-stimulating factor mobilization. Haematologica 85 (2000) 647-652
27. + CML patients in complete cytogenetic remission after long-term interferon-alpha therapy. Haematologica 84 (1999) 953-955
28. Meloni G., Russo D., Baccarani M., et al. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia. Haematologica 84 (1999) 707-715
29. The Italian Cooperative Study Group on Chronic Myeloid Leukaemia. Karyotype conversion by interferon as preparative treatment for autologous BMT in Ph positive CML. Leuk Lymphoma 11 suppl 1 (1993) 277-280
30. Reiffers J., Goldman J., Meloni G., Cahn J.Y., and Gratwohl A. Chronic Leukaemia Working Party of the EBMT. Autologous stem cell transplantation in chronic myelogenous leukaemia: A retrospective analysis of the European Group for Bone Marrow Transplant. Bone Marrow Transplant 14 (1994) 407-410
31. Goldman J.M. Treatment of chronic myeloid leukaemia: Some topical questions. Baillieres Clin Haematol 10 (1997) 405-421
32. Olavarria E., Reiffers J., Boque C., et al. The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase. Br J Haematol 118 (2002) 762-770
33. Spencer A., Granter N., Fagan K., et al. Collection and analysis of peripheral blood mononuclear cells during haemopoietic recovery following PBSCT for CML: Autografting as an in vivo purging manoeuvre?. Bone Marrow Transplant 21 (1998) 101-103
34. Meloni G., De Fabritiis P., and Alimena F. Autologous bone marrow transplantation or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase. Bone Marrow Transplant 4 suppl 4 (1990) 92-94
35. Khouri I.F., Kantarjian H., Talpaz M., et al. Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukaemia: The MD Anderson experience. Bone Marrow Transplant 17 (1996) 775-779
36. McGlave P.B., De Fabritiis P., Deisseroth J., et al. Autologous transplants for chronic myelogenous leukaemia: Results from eight transplant groups. Lancet 343 (1994) 1486-1488
37. Simonsson B., Oberg G., Bjoreman M., et al. Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: Long-term follow-up. Acta Haematol 113 (2005) 155-162
38. Apperley J.F., Boque C., Carella A., et al. Autografting in chronic myeloid leukaemia: A meta-analysis of six randomised trials. Bone Marrow Transplant 33 (2004) S28
39. Olavarria E., Kanfer E., Szydlo R., et al. High-dose busulphan alone as cytoreduction before allogeneic or autologous stem cell transplantation for chronic myeloid leukaemia: A single-centre experience. Br J Haematol 108 (2000) 769-777
40. Boiron J.M., Cahn J.Y., Meloni G., et al. Chronic myeloid leukaemia in first chronic phase not responding to α-interferon: Outcome and prognostic factors after autologous transplantation. Bone Marrow Transplant 24 (1999) 259-264
41. Kantarjian H.M., Smith T.L., O'Brien S., et al. Prolonged survival in chronic myelogenous leukemia following cytogenetic response to alpha interferon therapy. Ann Intern Med 122 (1995) 254-261
42. Mahon F.X., Faberes C., Pueyo S., et al. Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant alpha interferon. Blood 92 (1998) 4059-4065
43. The Italian Cooperative Study Group on Chronic Myeloid Leukaemia. Interferon alpha-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 330 (1994) 820-825
44. Reiffers J., Cahn J.Y., Montastruc M., et al. Peripheral blood stem cell transplantation followed by recombinant alpha interferon for chronic myelogenous leukemia in chronic phase: preliminary results. Stem Cells 11 (1993) 23-24
45. Carlo-Stella C., Regazzi E., Andrizzi C., et al. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Haematologica 82 (1997) 291-296
46. Gladstone D.E., Bedi A., Miller C.B., et al. Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia. Biol Blood Marrow Transplant 5 (1999) 394-399
47. Rowe J.M., Rapoport A.P., Ryan D.H., et al. Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex. Bone Marrow Transplant 24 (1999) 1057-1063
48. Rainey M.G., Harrison P., Hows J.M., et al. Spontaneous graft-versus-host disease following autologous peripheral blood progenitor cell transplantation in chronic myeloid leukaemia. Bone Marrow Transplant 17 (1996) 1077-1079
49. Drummond M.W., Marin D., Clark R.E., et al. Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission. Br J Haematol 123 (2003) 479-483
50. Kreuzer K.A., Kluhs C., Baskaynak G., et al. Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: Safety, feasibility and evidence for an efficient in vivo purging. Br J Haematol 124 (2004) 195-199
51. Perseghin P., Gambacorti-Passerini C., Tornaghi L., et al. Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate. Transfusion 45 (2005) 1214-1220
52. Hoyle C., Gray R., and Goldman J. Autografting for patients with CML in chronic phase: an update. Br J Haematol 86 (1994) 76-81
53. Enright H., and McGlave P. Bone marrow transplantation for chronic myelogenous leukemia. Curr Opin Oncol 10 (1998) 100-107